ReP USP - Resultado da busca

Artigo de periodico
Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle (2016)
Gagliano-Jucá, Thiago; Napolitano, Mauro; Carvalho, Fernanda Del Grossi Ferraz; Campos, Rafael; Mónica, Fabíola Zakia; Claudino, Mário Angelo; Antunes, Edson; Lopes, Anibal Gil; De Nucci, Gilberto
Source: Sexual Medicine. Unidade: ICB
Subjects: FARMACOLOGIA, DISFUNÇÃO ERÉTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAGLIANO-JUCÁ, Thiago et al. Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle. Sexual Medicine, v. 4, n. 2, p. e113-e123, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.esxm.2016.02.003. Acesso em: 29 jun. 2024.
APA
Gagliano-Jucá, T., Napolitano, M., Carvalho, F. D. G. F., Campos, R., Mónica, F. Z., Claudino, M. A., et al. (2016). Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle. Sexual Medicine, 4( 2), e113-e123. doi:10.1016/j.esxm.2016.02.003
NLM
Gagliano-Jucá T, Napolitano M, Carvalho FDGF, Campos R, Mónica FZ, Claudino MA, Antunes E, Lopes AG, De Nucci G. Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle [Internet]. Sexual Medicine. 2016 ; 4( 2): e113-e123.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.esxm.2016.02.003
Vancouver
Gagliano-Jucá T, Napolitano M, Carvalho FDGF, Campos R, Mónica FZ, Claudino MA, Antunes E, Lopes AG, De Nucci G. Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle [Internet]. Sexual Medicine. 2016 ; 4( 2): e113-e123.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.esxm.2016.02.003
Artigo de periodico
Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects (2016)
Mendes, Gustavo D.; Zaffalon, Gabriela Traldi; Silveira, Antonio Sérgio; Ramacciato, Juliana Cama; Motta, Rogério Heládio Lopes; Gagliano-Jucá, Thiago; Lopes, Anibal Gil; Magalhães, José Cássio de Almeida; De Nucci, Gilberto
Source: Biomedical Chromatography. Unidade: ICB
Subjects: ESPECTROMETRIA DE MASSAS, BIODISPONIBILIDADE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDES, Gustavo D. et al. Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects. Biomedical Chromatography, v. 30, n. 4, p. 536-542, 2016Tradução . . Disponível em: https://doi.org/10.1002/bmc.3579. Acesso em: 29 jun. 2024.
APA
Mendes, G. D., Zaffalon, G. T., Silveira, A. S., Ramacciato, J. C., Motta, R. H. L., Gagliano-Jucá, T., et al. (2016). Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects. Biomedical Chromatography, 30( 4), 536-542. doi:10.1002/bmc.3579
NLM
Mendes GD, Zaffalon GT, Silveira AS, Ramacciato JC, Motta RHL, Gagliano-Jucá T, Lopes AG, Magalhães JC de A, De Nucci G. Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects [Internet]. Biomedical Chromatography. 2016 ; 30( 4): 536-542.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/bmc.3579
Vancouver
Mendes GD, Zaffalon GT, Silveira AS, Ramacciato JC, Motta RHL, Gagliano-Jucá T, Lopes AG, Magalhães JC de A, De Nucci G. Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects [Internet]. Biomedical Chromatography. 2016 ; 30( 4): 536-542.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/bmc.3579
Artigo de periodico
Inhibition of human platelet aggregation by eosinophils (2013)
Maziero, Aline Mendes; Lorenzetti, Raquel; Donato, José Luiz; Lilla, Sergio; De Nucci, Gilberto
Source: Life Sciences. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZIERO, Aline Mendes et al. Inhibition of human platelet aggregation by eosinophils. Life Sciences, v. 93, n. 9-11, p. 416-422, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2013.07.012. Acesso em: 29 jun. 2024.
APA
Maziero, A. M., Lorenzetti, R., Donato, J. L., Lilla, S., & De Nucci, G. (2013). Inhibition of human platelet aggregation by eosinophils. Life Sciences, 93( 9-11), 416-422. doi:10.1016/j.lfs.2013.07.012
NLM
Maziero AM, Lorenzetti R, Donato JL, Lilla S, De Nucci G. Inhibition of human platelet aggregation by eosinophils [Internet]. Life Sciences. 2013 ; 93( 9-11): 416-422.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.lfs.2013.07.012
Vancouver
Maziero AM, Lorenzetti R, Donato JL, Lilla S, De Nucci G. Inhibition of human platelet aggregation by eosinophils [Internet]. Life Sciences. 2013 ; 93( 9-11): 416-422.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.lfs.2013.07.012
Artigo de periodico
Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice (2012)
Silva, F. H. da; Pereira, M. N.; Franco-Penteado, C. F.; De Nucci, Gilberto ; Antunes, E.; Claudino, M. A.
Source: International Journal of Impotence Research. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, F. H. da et al. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, v. 25, n. 2, p. 69-73, 2012Tradução . . Disponível em: https://doi.org/10.1038/ijir.2012.35. Acesso em: 29 jun. 2024.
APA
Silva, F. H. da, Pereira, M. N., Franco-Penteado, C. F., De Nucci, G., Antunes, E., & Claudino, M. A. (2012). Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, 25( 2), 69-73. doi:10.1038/ijir.2012.35
NLM
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/ijir.2012.35
Vancouver
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/ijir.2012.35
Artigo de periodico
Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training (2010)
Claudino, Mário A.; Franco-Penteado, Carla A.; Priviero, Fernanda B. M.; Camargo, Enilton A.; Teixeira, Simone Aparecida; Muscará, Marcelo Nicolás ; De Nucci, Gilberto ; Zanesco, Angelina; Antunes, Edson
Source: Urology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CLAUDINO, Mário A. et al. Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training. Urology, v. 75, n. 4, p. 961-7, 2010Tradução . . Acesso em: 29 jun. 2024.
APA
Claudino, M. A., Franco-Penteado, C. A., Priviero, F. B. M., Camargo, E. A., Teixeira, S. A., Muscará, M. N., et al. (2010). Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training. Urology, 75( 4), 961-7.
NLM
Claudino MA, Franco-Penteado CA, Priviero FBM, Camargo EA, Teixeira SA, Muscará MN, De Nucci G, Zanesco A, Antunes E. Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training. Urology. 2010 ; 75( 4): 961-7.[citado 2024 jun. 29 ]
Vancouver
Claudino MA, Franco-Penteado CA, Priviero FBM, Camargo EA, Teixeira SA, Muscará MN, De Nucci G, Zanesco A, Antunes E. Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training. Urology. 2010 ; 75( 4): 961-7.[citado 2024 jun. 29 ]
Artigo de periodico
Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces ß3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity (2008)
Mónica, F. Z. T.; Bricola, A. A. O.; Báu, F. R.; Lopes Freitas, L. L.; Teixeira, S. A.; Muscará, Marcelo Nicolás ; Abdalla, F. M. F.; Porto, C. S.; De Nucci, Gilberto ; Zanesco, A.; Antunes, E.
Source: British Journal of Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MÓNICA, F. Z. T. et al. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces ß3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity. British Journal of Pharmacology, v. 153, n. 8, p. 1659-1668, 2008Tradução . . Disponível em: https://doi.org/10.1038/bjp.2008.39. Acesso em: 29 jun. 2024.
APA
Mónica, F. Z. T., Bricola, A. A. O., Báu, F. R., Lopes Freitas, L. L., Teixeira, S. A., Muscará, M. N., et al. (2008). Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces ß3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity. British Journal of Pharmacology, 153( 8), 1659-1668. doi:10.1038/bjp.2008.39
NLM
Mónica FZT, Bricola AAO, Báu FR, Lopes Freitas LL, Teixeira SA, Muscará MN, Abdalla FMF, Porto CS, De Nucci G, Zanesco A, Antunes E. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces ß3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity [Internet]. British Journal of Pharmacology. 2008 ; 153( 8): 1659-1668.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/bjp.2008.39
Vancouver
Mónica FZT, Bricola AAO, Báu FR, Lopes Freitas LL, Teixeira SA, Muscará MN, Abdalla FMF, Porto CS, De Nucci G, Zanesco A, Antunes E. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces ß3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity [Internet]. British Journal of Pharmacology. 2008 ; 153( 8): 1659-1668.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/bjp.2008.39
Artigo de periodico
Toxin IV-5-accounts for the relaxing activity of Tityus serrulatus venom in the rabbit corpus carvenosum (2002)
Teixeira, Cleber Evandro; Ifa, Demian Rocha; Corso, G.; Antunes, Edson; De Nucci, Gilberto
Source: British Journal of Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Cleber Evandro et al. Toxin IV-5-accounts for the relaxing activity of Tityus serrulatus venom in the rabbit corpus carvenosum. British Journal of Pharmacology, v. 135, p. 208, 2002Tradução . . Acesso em: 29 jun. 2024.
APA
Teixeira, C. E., Ifa, D. R., Corso, G., Antunes, E., & De Nucci, G. (2002). Toxin IV-5-accounts for the relaxing activity of Tityus serrulatus venom in the rabbit corpus carvenosum. British Journal of Pharmacology, 135, 208.
NLM
Teixeira CE, Ifa DR, Corso G, Antunes E, De Nucci G. Toxin IV-5-accounts for the relaxing activity of Tityus serrulatus venom in the rabbit corpus carvenosum. British Journal of Pharmacology. 2002 ; 135 208.[citado 2024 jun. 29 ]
Vancouver
Teixeira CE, Ifa DR, Corso G, Antunes E, De Nucci G. Toxin IV-5-accounts for the relaxing activity of Tityus serrulatus venom in the rabbit corpus carvenosum. British Journal of Pharmacology. 2002 ; 135 208.[citado 2024 jun. 29 ]
Artigo de periodico
Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study (2002)
Moraes, Leonardo Augusto; Ribeiro, Wellington; De Nucci, Gilberto
Source: British Journal of Clinical Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Leonardo Augusto e RIBEIRO, Wellington e DE NUCCI, Gilberto. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology, v. 53, n. 4, p. 440-441, 2002Tradução . . Acesso em: 29 jun. 2024.
APA
Moraes, L. A., Ribeiro, W., & De Nucci, G. (2002). Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology, 53( 4), 440-441.
NLM
Moraes LA, Ribeiro W, De Nucci G. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology. 2002 ; 53( 4): 440-441.[citado 2024 jun. 29 ]
Vancouver
Moraes LA, Ribeiro W, De Nucci G. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology. 2002 ; 53( 4): 440-441.[citado 2024 jun. 29 ]
Artigo de periodico
Mycophenolate mofetil reduces renal injury inthe chronic nitric oxide synthase inhibition model (2001)
Fujihara, Clarice Kazue; Malheiros, Denise Maria Avancini Costa; Noronha, Irene de Lourdes; De Nucci, Gilberto ; Zatz, Roberto
Source: Hypertension. Unidade: FM
Assunto: FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, Clarice Kazue et al. Mycophenolate mofetil reduces renal injury inthe chronic nitric oxide synthase inhibition model. Hypertension, v. 37, p. 170-175, 2001Tradução . . Disponível em: http://hyper.ahajournals.org/cgi/content/abstract/37/1/170?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Fujihara%2C+C&searchid=984770939623_24993&stored_search=&FIRSTINDEX=&fdate=1/1/1998&search_url=http%3A%2F%2Fhyper.ahajournals.org%2Fcgi%2Fsearch&journalcode=hypertensionaha. Acesso em: 29 jun. 2024.
APA
Fujihara, C. K., Malheiros, D. M. A. C., Noronha, I. de L., De Nucci, G., & Zatz, R. (2001). Mycophenolate mofetil reduces renal injury inthe chronic nitric oxide synthase inhibition model. Hypertension, 37, 170-175. Recuperado de http://hyper.ahajournals.org/cgi/content/abstract/37/1/170?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Fujihara%2C+C&searchid=984770939623_24993&stored_search=&FIRSTINDEX=&fdate=1/1/1998&search_url=http%3A%2F%2Fhyper.ahajournals.org%2Fcgi%2Fsearch&journalcode=hypertensionaha
NLM
Fujihara CK, Malheiros DMAC, Noronha I de L, De Nucci G, Zatz R. Mycophenolate mofetil reduces renal injury inthe chronic nitric oxide synthase inhibition model [Internet]. Hypertension. 2001 ; 37 170-175.[citado 2024 jun. 29 ] Available from: http://hyper.ahajournals.org/cgi/content/abstract/37/1/170?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Fujihara%2C+C&searchid=984770939623_24993&stored_search=&FIRSTINDEX=&fdate=1/1/1998&search_url=http%3A%2F%2Fhyper.ahajournals.org%2Fcgi%2Fsearch&journalcode=hypertensionaha
Vancouver
Fujihara CK, Malheiros DMAC, Noronha I de L, De Nucci G, Zatz R. Mycophenolate mofetil reduces renal injury inthe chronic nitric oxide synthase inhibition model [Internet]. Hypertension. 2001 ; 37 170-175.[citado 2024 jun. 29 ] Available from: http://hyper.ahajournals.org/cgi/content/abstract/37/1/170?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Fujihara%2C+C&searchid=984770939623_24993&stored_search=&FIRSTINDEX=&fdate=1/1/1998&search_url=http%3A%2F%2Fhyper.ahajournals.org%2Fcgi%2Fsearch&journalcode=hypertensionaha
Artigo de periodico
Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers (1998)
David, F L; Da-Silva, C M; Mendes, F D; Ferraz, J G; Muscará, Marcelo Nicolás ; Moreno Junior, H; De Nucci, Gilberto ; Pedrazzoli Junior, J
Source: Alimentary Pharmacology and Therapeutics. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVID, F L et al. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers. Alimentary Pharmacology and Therapeutics, v. 12, n. 4, p. 349-354, 1998Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2036.1998.00298.x. Acesso em: 29 jun. 2024.
APA
David, F. L., Da-Silva, C. M., Mendes, F. D., Ferraz, J. G., Muscará, M. N., Moreno Junior, H., et al. (1998). Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers. Alimentary Pharmacology and Therapeutics, 12( 4), 349-354. doi:10.1046/j.1365-2036.1998.00298.x
NLM
David FL, Da-Silva CM, Mendes FD, Ferraz JG, Muscará MN, Moreno Junior H, De Nucci G, Pedrazzoli Junior J. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 4): 349-354.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1046/j.1365-2036.1998.00298.x
Vancouver
David FL, Da-Silva CM, Mendes FD, Ferraz JG, Muscará MN, Moreno Junior H, De Nucci G, Pedrazzoli Junior J. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 4): 349-354.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1046/j.1365-2036.1998.00298.x
Artigo de periodico
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori (1998)
Carvalho, A F; Fiorelli, L A; Jorge, V N; Da-Silva, C M; De Nucci, Gilberto ; Ferraz, J G; Pedrazzoli, J
Source: Alimentary Pharmacology and Therapeutics. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, A F et al. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics, v. 12, n. 6, p. 557-561, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0016-5085(98)80343-0. Acesso em: 29 jun. 2024.
APA
Carvalho, A. F., Fiorelli, L. A., Jorge, V. N., Da-Silva, C. M., De Nucci, G., Ferraz, J. G., & Pedrazzoli, J. (1998). Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics, 12( 6), 557-561. doi:10.1016/s0016-5085(98)80343-0
NLM
Carvalho AF, Fiorelli LA, Jorge VN, Da-Silva CM, De Nucci G, Ferraz JG, Pedrazzoli J. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 6): 557-561.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/s0016-5085(98)80343-0
Vancouver
Carvalho AF, Fiorelli LA, Jorge VN, Da-Silva CM, De Nucci G, Ferraz JG, Pedrazzoli J. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 6): 557-561.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/s0016-5085(98)80343-0
Artigo de periodico
Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease (1998)
Da-Silva, C M; David, F L; Muscará, Marcelo Nicolás ; Sousa, S S; Ferraz, J G; De Nucci, Gilberto ; Polimeno, N C; Pedrazzoli Junior, J
Source: British Journal of Clinical Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DA-SILVA, C M et al. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease. British Journal of Clinical Pharmacology, v. 46, n. 2, p. 176-180, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0016-5085(98)84997-4. Acesso em: 29 jun. 2024.
APA
Da-Silva, C. M., David, F. L., Muscará, M. N., Sousa, S. S., Ferraz, J. G., De Nucci, G., et al. (1998). Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease. British Journal of Clinical Pharmacology, 46( 2), 176-180. doi:10.1016/s0016-5085(98)84997-4
NLM
Da-Silva CM, David FL, Muscará MN, Sousa SS, Ferraz JG, De Nucci G, Polimeno NC, Pedrazzoli Junior J. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease [Internet]. British Journal of Clinical Pharmacology. 1998 ; 46( 2): 176-180.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/s0016-5085(98)84997-4
Vancouver
Da-Silva CM, David FL, Muscará MN, Sousa SS, Ferraz JG, De Nucci G, Polimeno NC, Pedrazzoli Junior J. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease [Internet]. British Journal of Clinical Pharmacology. 1998 ; 46( 2): 176-180.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/s0016-5085(98)84997-4

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation